Abstract -Recent evidence from a variety of laboratory studies suggests that the central effects of ethanol (EtOH) are mediated by serotonin 5-HT 3 receptors. Notably, EtOH is able to potentiate 5-HT action on 5-HT 3 ionophore, and 5-HT3 antagonists are known to reduce certain effects of EtOH. In the present study, we evaluated the effects of two agonists of 5-HT 3 receptors, 2-methyl-5-HT (2-Me-5-HT) and m-chlorophenylbiguanide (m-CPBG) that were microinjected i.c.v. and into the nucleus accumbens (NAC) on EtOH intake in Wistar rats with high EtOH preference. 2-Me-5-HT given i.c.v. (1 and 10ng per rat) and into the NAC (bilaterally 1 and 10 ug per site) significantly reduced EtOH intake in the limited access paradigm (2h session). On the other hand m-CPBG was inactive after intra-NAC administration. It is concluded that central 5-HT 3 receptors are involved in the regulation of EtOH consumption.
INTRODUCTION
The reinforcing mechanism of ethanol (EtOH), psychostimulants (such as amphetamines and cocaine) and morphine appears to involve stimulation of the mesolimbic dopaminergic system (Spyraki et al, 1982; Di Chiara and Imperato, 1988; Wise and Rompre, 1989; Fadda et al., 1991) . Like other substances of abuse, EtOH has been frequently reported to activate this system by increasing the firing of neuronal cells located within the ventral tegmental area (VTA) (Gessa et al., 1985) and by stimulating dopamine (DA) release from the DA mesolimbic neurons (Di Chiara and Imperato, 1988; Wozniak et al, 1990; Fadda et al., 1991; Yoshimoto et al, 1992) .
There is evidence that at least some central effects of EtOH are mediated through serotonergic 5-HT 3 receptors. In addition to influencing the y-aminobutyrate (GABA) A , glutamate (A'-methyl-D-aspartate; NMDA) and M-cholinergic receptors, EtOH is known to potentiate the action of serotonin (5-HT) on the 5-HT 3 receptor-ionophore complex (Lovinger, 1990; Lovinger and Zhou, 1994) . The 5-HT 3 receptor is linked to cation *Author to whom correspondence should be addressed. channels which conduct primarily Na + and K + ions (Derkach et al, 1989) and are located in the brain stem, cortical areas and limbic structures, including the entorhinal cortex, amygdala and nucleus accumbens (NAC) (Barnes et al, 1990 (Barnes et al, , 1992 Kilpatrick et al, l990a,b; Kilpatrick and Tyers, 1992) . Consistent with their localization within the limbic areas, 5-HT 3 receptors have been reported to influence dopaminergic neurotransmission. Notably, 5-HT 3 receptor antagonists such as ondansetron and tropisetron have been found to antagonize the hyperactivity following the administration of cocaine, amphetamine and EtOH (Costall et al, 1987; Blandina et al, 1989; Reith, 1990; Kostowski et al, 1995) and to reduce DA release in the NAS induced by nicotine, morphine and EtOH (Blandina et al, 1989; Carboni et al, 1989; Kennett and Blackbourn, 1991; Sellers et al, 1992) . In line with these observations is the notion that 5-HT 3 antagonists are capable of reducing the rewarding effect of certain psychoactive drugs, such as morphine and nicotine (Carboni et al, 1988; Higgins et al, 1992) in the conditioned place preference paradigm.
whether 5-HT 3 antagonists alter this phenomenon (e.g. Oakley et al, 1988; Fadda et al., 1991; Knapp and Pohorecky, 1992; Tomkins and Sellers, 1992; Hodge et al., 1993; Kostowski et al., 1993 Kostowski et al., , 1994 Meert, 1993; Tomkins et al., 1995) . However, the effect of agonists of the 5-HT 3 receptor on EtOH intake has not been evaluated. Theoretically, the 5-HT 3 receptor could play a role in the motivation and reinforcing mechanisms, as stimulation of this receptor results in the release of DA but also influences the release of other neurotransmitters such as acetylcholine (ACh), GABA, noradrenaline (NA) and cholecystokinin (CCK) (Blandina et al., 1989; Paudice and Raiteri, 1991; Barnes et al., 1992; Kilpatrick and Tyers, 1992; Lydiard, 1994) . We decided therefore, to investigate the effect of two 5-HT 3 agonists: 2-methyl-serotonin (2-Me-5-HT) and m-(chlorophenyl)-biguanide (zn-CPBG) on EtOH consumption in rats. Both drugs are the preferred 5-HT 3 agonists; the latter being appreciably more potent, and, unlike 2-Me-5-HT, it has no significant effects on other 5-HT receptors (Steward et al., 1993; Hoyer et al., 1994 for review). While 5-HT and 2-Me-5-HT show broadly similar activity in a variety of binding assays, the arylbiguanides (such as m-CPBG and phenylbiguanide) are less active in certain tissues than others (see Hoyer et al., 1994) . Both 2-Me-5-HT and m-CPBG penetrate poorly into the brain, and after their peripheral administration the most obvious behavioural effects are writhing and abdominal constriction (Higgins et al., 1993) . We decided, therefore, to administer these compounds by i.c.v. microinjection and directly into the NAC, i.e. the area in which interaction between 5-HT 3 receptors and DA neurotransmission has been reported (see Jiang et al., 1990; Kennett and Blackbourn, 1991; Barnes et al., 1992) .
MATERIALS AND METHODS

Animals
Male Wistar rats (180-200 g at the beginning of the experiment) were housed individually in wire mesh cages (25 x 20 x 35 cm) at 21-22°C, 60% relative humidity and under 12:12h light-dark cycle (light on at 08.00). The rats had free access to granulated food, but access to tap water was limited (see below).
Selection of EtOH-preferring rats
To obtain rats preferring EtOH a procedure described previously by us was used (Kostowski et al., 1993 (Kostowski et al., , 1994 . Briefly, during the first week of the study, animals received 20% (v/v) EtOH solution intragastrically twice daily (5.0 g/kg/ day). They had free access to commercial chow and tap water. During the next 2 weeks, rats had free access to tap water only 1 h per day, whereas during the remaining 23 h the only source of fluid was 5% EtOH solution (2nd week) and 10% EtOH solution (3rd week). During the next (i.e. 4th) week, the animals were presented with a free choice (two bottles) between water and 10% EtOH solution. Measurement of fluid intake and refilling were performed every day (at 09.00-10.00) when the positions of water and EtOH bottles were exchanged. A high-preference group (HP) was selected on the basis of the EtOH and water intake. The total fluid intake (g/kg/24 h) and the absolute EtOH intake (g/kg/24 h) were calculated. Animals consuming ^5.0 g/kg/24 h of absolute EtOH were considered as HP and were used for the further study.
Surgery
The animals were anaesthetized with ketamine (75 mg/kg, i.p.) and placed in a Stoelting stereotaxic apparatus (Stoelting Co., USA). Guiding cannulae were implanted bilaterally with their tips ending 2 mm above the injection site within the NAC [the coordinates according to Pellegrino et al. (1979) were: A = 3.2 mm from bregma, L = 1.5 mm, V = 6.5 mm from dura, and unilaterally into the third (right side) ventricle (P = 0.8 mm, L = 2.5 mm, V = 3.0 mm)].
Limited access to EtOH procedure and treatment
One week after completing surgical procedure, a regimen of scheduled access to EtOH was initiated to study the effect of drugs injected i.c.v. and into the NAC. A 10% (v/v) EtOH solution was available for 2h per day between 10.00 and 12.00 a.m. This scheduled access paradigm regularizes EtOH intake so that the effects of drugs can be consistently evaluated. EtOH intake from graduated drinking tubes was measured at 15, 30, 60 and 120 min of each daily scheduled access.
After establishing this basal EtOH intake, the rats were microinjected either with 5-HT 3 agonist or 0.9% (w/v) NaCl. The EtOH consumption was measured 15, 30, 60 and 120 min following microinjection, when animals had free access to food, water and EtOH solution. The intakes of EtOH were quantified in terms of ml of 10% EtOH solution per rat per 2 h (the absolute EtOH amount consumed in g/kg body weight was also measured but not shown in the Results section). The proportion of EtOH to total fluid was not calculated since the amount of water drunk during the 2 h session was very low and practically negligible (see Results).
Measurements of the water and food intake
Food and water intakes in freely fed rats were measured as follows: 7 days after implantation of i.c.v. cannulae, singly-housed animals were allowed free access to powdered food (obtained from standard laboratory chow) from a specially constructed feeder preventing the spillage. Before experimentation, rats were habituated 3 days in order to obtain a stable daily level of food and water consumed. During the experimental session, drugs or saline were microinjected i.c.v. twice daily (09.00 and 16.00) and daily food intake and water consumption (g/rat/24 h) were recorded.
A subsequent session with food-deprived rats began 7 days later. Food was removed at the start of the test session (water was available at all times) for 22 h and then was allowed for the remaining 2 h. The amount of food and water consumed was then measured (g/rat/2 h). The mean weights of rats in each group did not differ significantly.
Histology
At the end of the experiment, the rats were anaesthetized with ketamine and decapitated. The brain of each animal was removed, sectioned on a freezing microtome and histological placements of cannulae were identified using the atlas of Pellegrino et al. (1979) . Rats with cannulae implanted into the right ventricle were microinjected 1 min before decapitation with 1.0 ul of methylene blue.
Drugs and microinjections
The following drugs were used: l-(m-chlorophenyl)-biguanide hydrochloride (RBI, Natick, USA) and 2-methyl-5-hydroxytryptamine hydrogen maleanate (Sandoz, Basel). Drugs were dissolved in 0.9% (v/v) sodium chloride solution, controls received saline only.
Animals received either 1 or 10 ug of drugs into each NAC in a volume of 1.0 ul at the flow rate of l.Oul/min. For i.c.v. administration, drugs were microinjected in doses of 1 and 10 ug in a volume of 5 ul at the flow rate of 2.5 ul/min. The micropump CMA 100 (Carnegie, Sweden) was used.
Statistics
The results were analysed using two-way analysis of variance (ANOVA) followed by posthoc Newman-Keuls test to determine individual differences.
RESULTS
Location of cannulae tips
Histological examination (frozen microtome sections) showed that cannula tips were located mainly with the dorsal and middle portion of NAC (five animals in which cannulae were not properly positioned were discarded from the analysis of results). All the animals with i.c.v. cannulae showed proper location of cannula tips (as shown by use of methylene blue microinjection).
Effects of 5-HT 3 agonists
The results are given as the 10% EtOH solution intake data (ml/rat/2 h), as these were comparable to absolute ethanol intake data, which are not shown.
Of the total 89 rats used for EtOH intake study, 35 became high-preferring (HP). The average baseline intake of HP rats selected for the limited EtOH access paradigm was 7.65 ± 0.77 g/kg/24 h, with a mean preference to EtOH of 59.6%.
The average baseline intake of EtOH per 2 h scheduled access session was 0.85 ± 0.3 g/kg or 4.5 ± 0.6 ml of 10% EtOH solution/rat/2 h. Water intake by the HP rats during this session was very low and did not exceed 0.15 ml/rat/2 h (data not shown).
Intraventricular microinjections of saline produced no effect on intake of the EtOH solution (or only and temporary early reduction) while administration of 2-Me-5-HT markedly reduced EtOH consumption, the effect lasting during the whole cantly (P < 0.01) increased the amount of food consumed during the 2 h session, with water intake remaining unchanged (Table 1) .
DISCUSSION
The data from the present study indicate that i.c.v. administration of 5-HT 3 agonists reduces consumption of a 10% EtOH solution in highalcohol-consuming Wistar rats, the effect of 2-Me-5-HT being more potent when compared with m-CPBG. Surprisingly, when drugs were microinjected into the NAS only 2-Me-5-HT was capable of suppressing EtOH intake.
It is not clear what mechanisms may account for the reduction of EtOH intake by 5-HT 3 agonists nor why 2-Me-5-HT was more potent than m-CPBG, particularly after intra-NAC administration. A simple effect on food and water intake is observation period (Fig. 1) . Two-way ANOVA showed significant reduction in consumption of the 10% EtOH solution (F 3>20 = 4.33, P<0.01). Also, m-CPBG (10 ug i.c.v.) reduced significantly EtOH consumption (F 3i96 = 62.34, P < 0.01); the effect of lower dose (1.0 ug) was, however, of a short duration, disappearing after 120 min (Fig. 2) . When administered into the NAC, 2-Me-5-HT produced a marked and long-lasting suppression of EtOH consumption. ANOVA analysis showed significance in the 10% EtOH solution intake (^3.20=10.59, P< 0.001, Fig. 3 ). By contrast, administration of w-CPBG into the NAC produced no significant effects (F 3>2 8 = 1.16, Fig. 4) .
Intraventricular administration of 5-HT agonists (10 ug) failed to influence food and water intake in freely-feeding rats, while in food-deprived animals 2-Me-5-HT (but not w-CPBG) signifi- rewarding mechanisms, as ondansetron has been reported to reduce palatable food consumption in non-deprived rats (Van der Hoek and Cooper, 1994) . There is evidence that, in addition to facilitation of DA release, activation of 5-HT3 receptors modulates the release of other neurotransmitters including CCK, ACh, GABA and NA (Kilpatrick et al., \990a,b\ Paudice and Raiteri, 1991) . Assuming such actions to be physiologically important, these findings may provide a basis for a modulatory action on EtOH consumption. For example, release of CCK may be associated with anxiogenic effects (Lydiard, 1994) . In fact, i.c.v. injections of various 5-HT 3 agonists have been reported to produce behaviours indicative of anxiety in rats (Mitchell et al, 1991; Higgins et al., 1993) . The significance of this effect is, however, difficult to evaluate as relatively higher 0 30 60 90 120
Minutes Fig. 3 . The effects of bilateral intra-accumbens microinjections of 2-Me-5-HT on 10% EtOH solution intake, during 2 h access period. Values are means ± SEM (bars) for 6 rats/group. **P < 0.01 vs NaCl. D, baseline; O, NaCl; A, 2-Me-5-HT, 1 ng; •, 2-Me-5-HT, 10 ng.
unlikely, as both compounds were unable to reduce the amount of food and water consumed by freely-feeding and to a large extent also fooddeprived animals. There is no plausible explanation why 2-Me-5-HT (but not m-CPBG) increased feeding in food-deprived rats; mechanisms other than 5-HT3 receptor-related ones may play a role in this phenomenon. The implications of 5-HT 3 receptors in control of feeding behaviour is not clear, as the anorectic effect of a 5-HT releaser, d-fenfluramine, does not depend on this receptor (Neil and Cooper, 1989) . Also, the evidence from experiments with various 5-HT 3 antagonists is inconclusive (Di Chiara and Imperato, 1988; Neil and Cooper, 1989) . Recent data reported by Mazzolapomietto et al. (1995) do not support an important role for 5-HT 3 receptors in the regulation of food intake in rats. However, these receptors seem to play a role in regulating Regarding the intra-accumbens injection study, it should be mentioned that there seems to be little doubt, based on autoradiographic and biochemical evidence, that 5-HT 3 receptors are located within this area (Barnes et al., 1990) . On the other hand, numerous studies have reported that 5-HT 3 agonists facilitate DA release within the NAC as well as striatum (Chen et al., 1981; Jiang et al., 1990; Barnes et al., 1992; Higgins et al., 1993) , thus it may be that receptor density is below the limits for detection (see Higgins et al., 1993) . This is true particularly for mice, rabbits and monkeys, but not for rats which contain a higher density of 5-HT 3 sites within the NAC as measured by specific binding of [ 3 H]GR 65630, the selective antagonist of 5-HT 3 receptors (see Kilpatrick et al., l990a, b) . The specific binding of this ligand to homogenates of discrete regions of the rat brain showed moderate density of 5-HT 3 binding sites within the limbic areas such as amygdala (7.2 fmol/mg of protein), hippocampus (4.2 fmol/ mg of protein) and NAC (4.2 fmol/mg of protein). Higher density of 5-HT 3 sites occurs in the brain stem, e.g. the area postrema (29.2 fmol/mg of protein) (Kilpatrick et al, l990a, b) .
The present finding that 2-Me-5-HT was more potent than w-CPBG in suppressing EtOH intake may have various putative explanations. First, there is a substantial difference between these compounds in terms of affinity to 5-HT 3 sites in different brain areas and affinity to other receptors. Radioligand binding data indicate that w-CPBG preferentially labels the areas with high density of 5-HT 3 sites, e.g. solitary tract and area postrema (Steward et al., 1993) . Interestingly [ 3 H]/n-CPBG almost fails to label 5-HT 3 sites within the forebrain areas (Steward et al., 1993) . Such a phenomenon might be due to the relatively low specific activity of the radioligand or the prevalent activity of sites other than those for 5-HT 3 (Steward et al., 1993) . However, other reports describing w-CPBG as a potent, highaffinity 5-HT 3 receptor agonist (e.g. Kilpatrick et al., 1990a) are not in line with this explanation.
The affinity of 5-HT 3 agonists towards receptors other than those of 5-HT 3 cannot be disregarded. It is to be noted that 2-Me-5-HT shows a moderate affinity for 5-HT 2 receptors (Ashby et al., 1991; Higgins et al., 1993) , i.e. the binding sites supposedly involved in the mechanism of EtOH intake (Panocka and Massi, 1992) . Also, w-CPBG has been reported to facilitate NA release by blockade of cortical <X2-adrenoceptors (Schlicker et al., 1994) .
Second, 2-Me-5-HT and w-CPBG may act on various 5-HT 3 receptor subtypes. To our knowledge, no strong evidence is yet available for the existence of different 5-HT 3 receptor ligands in the mouse cortex and ileum (Bonhaus et al., 1993; Hoyer et al., 1994) .
Finally, it is noteworthy that a substantial difference exists between w-CPBG and 2-Me-5-HT in terms of the release of DA within the NAC. While the effect of 2-Me-5-HT is exclusively due to stimulation of 5-HT 3 receptors, that of w-CPBG (as well as phenylbiguanide) may be due in part to influencing the DA transporter (Higgins et al., 1993; Campbell et al., 1995) .
In conclusion, we have reported that a 5-HT 3 agonist, 2-Me-5-HT, administered i.c.v. and into the NAC markedly reduces EtOH consumption in high-preferring rats in an ethanol limited access paradigm. The effect of m-CPBG is weak and occurs only after i.c.v. but not intra-NAC injection. A clearer interpretation as to the nature of these effects may come from further studies. Nevertheless, the present data suggest an involvement of the 5-HT 3 receptor in EtOH consumption.
